Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-22,990
Closed -$521K 671
2016
Q3
$521K Buy
22,990
+1,635
+8% +$35.7K 0.01% 501
2016
Q2
$404K Sell
21,355
-260,020
-92% -$5.43M 0.01% 531
2016
Q1
$7.36M Sell
281,375
-63,900
-19% -$1.48M 0.18% 141
2015
Q4
$8.89M Buy
345,275
+188,110
+120% +$5.08M 0.21% 140
2015
Q3
$3.53M Buy
+157,165
New +$4.03M 0.13% 206

Other funds holding TBI

Boston Advisors's TBI Position: Q4 2016 in Review

Boston Advisors sold out of Trueblue (TBI) in Q4 2016, closing a stake of 22,990 shares — an estimated $521K sold.

Boston Advisors first reported a position in TBI in Q3 2015 and held it in 5 quarters. The position peaked at $8.89M in Q4 2015. 183 funds tracked by Wall St. Rank hold TBI as of Q4 2016.

  • Boston Advisors reported no remaining Trueblue position as of Q4 2016 after selling out during the quarter.
  • Boston Advisors sold 22,990 Trueblue shares in Q4 2016, an estimated $521K.
  • Boston Advisors first reported a position in Trueblue in Q3 2015 and held it in 5 quarters.
  • Boston Advisors's Trueblue position peaked at $8.89M in Q4 2015.
  • 183 funds tracked by Wall St. Rank held Trueblue as of Q4 2016.

Based on Boston Advisors's 13F filing for Q4 2016, filed 25 Jan 2017.